![]() |
市场调查报告书
商品编码
1479113
语音辅助设备市场:现况分析与预测(2023-2030)Speech Aid Devices Market: Current Analysis and Forecast (2023-2030) |
由于口腔癌患者的增加,语音辅助设备市场预计将稳定成长约7.4%。例如,根据Journal of Pharmaceutical Sciences and Research报导,印度每年每 100 万人中有 20 人被诊断出患有口腔癌,占所有癌症的 30%。在大多数情况下,治疗涉及喉切除术,其中包括切除喉部或声带,使患者无法说话。包括医疗保健领域医疗设备的不断发展在内的多种因素正在推动预测期内的市场成长。除此之外,语音辅助技术的进步也正稳步推动语音辅助市场的发展。
依类型划分,市场分为电子喉语音辅助器、语音生成设备等。由于产品推出数量的增加,电子喉语音辅助领域在2022年占据市场主导地位。例如,2024 年 1 月,Whispp 推出了一款革命性的人工智慧语音呼叫辅助应用程序,具有最先进的电话呼叫功能,可将耳语和声带受损的声音即时转换为用户的自然语音。盒。电喉是一种电池供电的设备,供因喉癌等手术而失去喉部的人使用。透过产生声音振动并将这些振动传递到喉咙和嘴巴,可以利用嘴唇和舌头等口腔结构发出语音。该设备放置在脖子上或放在嘴里,使用者可以控制所产生声音的音调和响度。因此,在类型中,电子喉语音辅助器细分市场在2022年占据了重要的市场占有率。
依适应症,市场分为失语症、喉部相关疾病等。由于喉癌患者的增加,2022年喉相关疾病领域占据了很大的市场。例如,根据美国国家癌症研究所的数据,每年每 10 万名男性和女性中有 2.7 例喉癌新病例。言语辅助设备中与喉部疾病相关的部分已显示出显着增长。喉癌是喉部相关疾病的主要原因之一。随着喉癌发病率持续上升,人们越来越需要语音辅助设备来帮助人们在喉切除术后恢復和维持沟通能力。语音辅助器市场中喉部相关疾病部分的增长反映了喉部疾病患病率的日益增加以及帮助患有这些疾病的人实现更好的沟通效果的技术解决方案的扩展。因此,到 2022 年,喉相关疾病类别将在市场中占据重要占有率。
为了更瞭解语音辅助设备的市场介绍,将市场分为北美(美国、加拿大、北美其他地区)、欧洲(德国、英国、法国、西班牙、义大利、欧洲其他地区)、亚太地区(中国、日本、印度、亚太地区其他地区)和世界其他地区。在目前的 2022 年情况下,由于喉癌患者的快速增加、研发活动支出的增加、研究计划的增加、对引进创新进展的投资以及企业合作的增加,北美将主导市场。例如,2021年10月,美国语音復原和耳鼻喉产品製造商InHealth Technologies为接受全喉切除术的人推出了Blom-Singer SpeakFree HME免持阀。因此,依地区划分,北美将在 2022 年占据较大市场占有率。
市场主要参与者包括:Tobii Dynavox AB;PRC-Saltillo;Lingraphica;Atos Medical US;Attainment Company, Inc;Jabbla;Sentient Healthcare;Luminaud, Inc;Nu-Vois LLC;Andreas Fahl Medizintechnik-Vertrieb GmbH 等。
A speech aid device is a tool designed to assist individuals who have difficulty speaking or communicating verbally. These devices can range from simple tools like communication boards or picture cards to more advanced technology like speech-generating devices that use synthesized speech to vocalize typed or selected messages. These devices play a crucial role in enabling individuals with speech impairments to express themselves and communicate effectively with others. The increasing demand for speech aid devices has led to the market's growth. Several other factors, such as rising research & development activities, rising regulatory support, and a surge in government collaborations & partnerships are driving the speech aid devices market globally.
The Speech Aid Devices Market is expected to grow at a steady rate of around 7.4% owing to the rising number of oral cancer cases. For instance, according to the Journal of Pharmaceutical Sciences and Research, in India 20 out of every 1,00,000 people suffer from oral cancer yearly, which is 30% of all types of cancers. The majority of these cases involve laryngectomy as a part of the treatment where the larynx or voice box is removed, ceasing the ability to speak. Several factors, including the rising development of medical devices in healthcare, are driving the market's growth during the forecast period. Apart from this, technological advancements in speech aid devices are also driving this market of speech aid devices at a steady rate.
Based on the type, the market is segmented into electronic larynx speech aid devices, speech-generating devices, and others. The electronic larynx speech aid devices segment dominated the market in the year 2022 owing to the rising number of product launches. For instance, in January 2024, Whispp introduced electronic larynx voice boxes with its groundbreaking AI-powered assistive speech and phone-calling app which has the newest phone-calling feature that converts whispered and vocal cord-impaired speech into a user's natural voice in real-time. An electrolarynx is a battery-operated device used by individuals who have lost their larynx, typically due to surgery for conditions like throat cancer. It works by generating sound vibrations that are transferred to the throat and mouth, allowing the user to produce speech by articulating with the lips, tongue, and other oral structures. The device is held against the neck or placed in the mouth, and the user controls the pitch and volume of the sound produced. Thus, among the types, the electronic larynx speech aid devices segment held a significant market share in 2022.
Based on the indication, the market is categorized into aphasia, larynx-related disorders, and others. The larynx-related disorders segment held a significant share of the market in the year 2022 owing to the rising cases of laryngeal cancer. For instance, according to the National Cancer Institute, the rate of new cases of laryngeal cancer is 2.7 per 100,000 men and women per year. The segment of speech aid devices related to larynx disorders has seen notable growth. Laryngeal cancer is one of the leading causes of larynx-related disorders. As the incidence of laryngeal cancer continues to rise, there is a greater need for speech aid devices to help individuals regain or maintain their ability to communicate following laryngectomy. The growth of the larynx-related disorders segment in the speech aid devices market reflects both the increasing prevalence of laryngeal disorders and the expanding range of technological solutions available to support individuals with these conditions in achieving better communication outcomes. Thus, the larynx-related disorders category held a significant share of the market in the year 2022.
For a better understanding of the market adoption of speech aid devices, the market is analyzed based on its worldwide presence in countries such as North America (U.S., Canada, and the Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. North America is dominating the market in the current scenario of 2022 due to the surge in cases of laryngeal cancer, rising expenditure on research & development activities, rising research initiatives, investments in introducing innovative advancements, and rising company collaborations. For instance, in October 2021, U.S-based InHealth Technologies, a manufacturer of voice restoration and ENT products launched Blom-Singer SpeakFree HME Hands-Free Valve for people who have undergone a total laryngectomy. Thus, amongst regions, North America held a significant share of the market in 2022.
Some of the major players operating in the market include Tobii Dynavox AB; PRC-Saltillo; Lingraphica; Atos Medical US; Attainment Company, Inc.; Jabbla; Sentient Healthcare; Luminaud, Inc.; Nu-Vois LLC; Andreas Fahl Medizintechnik-Vertrieb GmbH.